Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival

British Journal of Haematology

Volumn 161, Issue 6, 2013, Pages 884-888

  Diakiw, Sonya M ^a,b   Perugini, Michelle ^a,b   Kok, Chung H ^a,b   Engler, Grant A ^a,b   Cummings, Nik ^c   To, Luen Bik ^a,b,d   Wei, Andrew H ^c   Lewis, Ian D ^a,b,d   Brown, Anna L ^a,b,e   D'Andrea, Richard J ^a,b,e  

^a SA Pathology   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

^e QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Acute myeloid leukaemia; Kr ppel like factor 5; Methylation; Prognostic biomarkers; Transcriptional regulation

Indexed keywords

KRUPPEL LIKE FACTOR 5;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLELE; BONE MARROW; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOME; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; INTRON; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MISSENSE MUTATION; MONONUCLEAR CELL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA METHYLATION; HUMANS; INTRONS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LEUKEMIA, MYELOID, ACUTE;

EID: 84878485138     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12295     Document Type: Letter

References (10)

1. Diakiw, S.M., Kok, C.H., To, L.B., Lewis, I.D., Brown, A.L. & D'Andrea, R.J. (2012) The granulocyte-associated transcription factor Kruppel-like factor 5 is silenced by hypermethylation in acute myeloid leukemia. Leukemia Research, 36, 110-116.
2. Dong, J.T. & Chen, C. (2009) Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cellular and Molecular Life Sciences, 66, 2691-2706.
3. Grimwade, D., Hills, R.K., Moorman, A.V., Walker, H., Chatters, S., Goldstone, A.H., Wheatley, K., Harrison, C.J. & Burnett, A.K. (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood, 116, 354-365.
4. Humbert, M., Halter, V., Shan, D., Laedrach, J., Leibundgut, E.O., Baerlocher, G.M., Tobler, A., Fey, M.F. & Tschan, M.P. (2011) Deregulated expression of Kruppel-like factors in acute myeloid leukemia. Leukemia Research, 35, 909-913.
5. Kamalakaran, S., Varadan, V., Giercksky Russnes, H.E., Levy, D., Kendall, J., Janevski, A., Riggs, M., Banerjee, N., Synnestvedt, M., Schlichting, E., Karesen, R., Shama Prasada, K., Rotti, H., Rao, R., Rao, L., Eric Tang, M.H., Satyamoorthy, K., Lucito, R., Wigler, M., Dimitrova, N., Naume, B., Borresen-Dale, A.L. & Hicks, J.B. (2011) DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables. Molecular Oncology, 5, 77-92.
6. Kwak, M.K., Lee, H.J., Hur, K., Park, J., Lee, H.S., Kim, W.H., Lee, K.U., Choe, K.J., Guilford, P. & Yang, H.K. (2008) Expression of Kruppel-like factor 5 in human gastric carcinomas. Journal of Cancer Research and Clinical Oncology, 134, 163-167.
7. Marcucci, G., Haferlach, T. & Dohner, H. (2011) Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. Journal of Clinical Oncology, 29, 475-486.
8. Oishi, Y., Manabe, I., Imai, Y., Hara, K., Horikoshi, M., Fujiu, K., Tanaka, T., Aizawa, T., Kadowaki, T. & Nagai, R. (2010) Regulatory polymorphism in transcription factor KLF5 at the MEF2 element alters the response to angiotensin II and is associated with human hypertension. FASEB Journal, 24, 1780-1788.
9. Thomas, X. (2012) DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences. Expert Opinion on Drug Discovery, 7, 1039-1051.
10. Yanagi, M., Hashimoto, T., Kitamura, N., Fukutake, M., Komure, O., Nishiguchi, N., Kawamata, T., Maeda, K. & Shirakawa, O. (2008) Expression of Kruppel-like factor 5 gene in human brain and association of the gene with the susceptibility to schizophrenia. Schizophrenia Research, 100, 291-301.